Filer Snapshot

Rabia Gurses Ozden

CIK 0001814883. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

26

Latest filing

10 Dec 2025

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for OCUL. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open owner activity Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G
Source: SEC Forms 3/4/5

4 filed on 10 Dec 2025 for CIK 0001814883.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

Forms 3/4/5 positions$801.9K

Reporting-owner positions with enough filing detail to estimate value.

Forms 3/4/5 position value

3/4/5
$801.9K

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

OCUL ADVM
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
C/O Adverum Biotechnologies, Inc., 100 Cardinal Way, Redwood City, CA, 94063

Filer intelligence

What SEC filings say about Rabia Gurses Ozden

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • Forms 3/4/5 show insider context for OCUL worth $743.8K.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

OCUL

03 Feb 2024 · Chief Medical Officer

$743.8K
Issuer page Owner page

ADVM

09 Dec 2025 · Chief Medical Officer

$58.1K
Issuer page Owner page

Latest update

What changed recently for Rabia Gurses Ozden

Ownership report updated

Latest ownership report period: 09 Dec 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

10 Dec 2025

Page type

Ownership filings

Latest period

09 Dec 2025

Ownership context was refreshed from SEC Forms 3/4/5 filed on 10 Dec 2025.

Open ownership filings Browse recent public updates

SEC filing record

CIK 0001814883 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
26
First seen
25 Jun 2020
Latest filing
10 Dec 2025
Entity
Individual

Observed form types

4 144 3

CIK-linked evidence first

Rabia Gurses Ozden SEC filings Rabia Gurses Ozden owner filings Open SEC filing index

Latest Filings

Showing the latest 12 of 26 SEC filings for Rabia Gurses Ozden.

Open full filing history
4 File 001-36579

4 filing

Filing date
10 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36579

4 filing

Filing date
20 Jun 2025
Reporting date
17 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36579

4 filing

Filing date
27 Feb 2025
Reporting date
25 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
27 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
21 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
07 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36579

4 filing

Filing date
06 Aug 2024
Reporting date
02 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
17 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
16 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
15 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
12 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144

144 filing

Filing date
09 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .